In the current study, HBO treatment may alleviate HFD-induced fatty acid metabolism dysfunction/obesity in C57/B6 mice, which seems to be associated with corrected circulation and skeletal muscle L-carnitine levels and PPARα expression levels. The gene discussed is PPARA; the disease is Obesity.